Récepteur α2-adrénergique And NotR. Raisman-Vozari
List of bibliographic references
Number of relevant bibliographic references: 12.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000C24 | Marc R. Marien [France] ; Francis C. Colpaert [France] ; Alan C. Rosenquist [France, États-Unis] | Noradrenergic mechanisms in neurodegenerative diseases: a theory |
| 000D82 | S. Baker [France] ; E. Moyse [France] ; F. Jourdan [France] ; F. Colpaert [France] ; J. C. Martel [France] ; M. Marien [France] | Effects of the α2-ADRENORECEPTOR antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: Selective protection against neuronal death |
| 000E30 | Anne-Marie Bonnet [France] | Récepteurs α2-adrénergiques et maladie de Parkinson |
| 001064 | O. Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France] | Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease |
| 001190 | Patrice Mayer [France] ; Pascale Brunel [France] ; Céline Chaplain [France] ; Christel Piedecoq [France] ; Francis Calmel [France] ; Philippe Schambel [France] ; Philippe Chopin [France] ; Thierry Wurch [France] ; Petrus J. Pauwels [France] ; Marc Marien [France] ; Jean-Louis Vidaluc [France] ; Thierry Imbert [France] | New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with α2-Adrenoceptor antagonist activity |
| 001345 | E. Bezard [France] ; C. Brefel [France] ; F. Tison [France] ; H. Peyro-Saint-Paul [France] ; P. Ladure [France] ; O. Rascol [France] ; C. E. Gross [France] | Effect of the α2 adrenoreceptor antagonist, idazoxan, on motor disabilities in mptp-treated monkey |
| 001403 | J. M. Senard [France] ; J. L. Montastruc [France] | Approche pharmacologique des dysautonomies |
| 001407 | C. Brefel-Courbon [France] ; C. Thalamas [France] ; H. Peyro Saint Paul [France] ; J.-M. Senard [France] ; J.-L. Montastruc [France] ; O. Rascol [France] | α2-Adrenoceptor antagonists: A new approach to Parkinson's disease? |
| 001788 | M. Galinier [France] ; J. M. Senard [France] ; P. Valet [France] ; J. P. Doazan [France] ; G. Durrieu [France] ; M. A. Tran [France] ; J. L. Monstastruc [France] ; J. P. Bounhoure | Relationship between arterial blood pressure disturbances and alpha adrenoceptor density |
| 001874 | J. M. Senard [France] ; O. Rascol [France] ; A. Rascol ; J. L. Montastruc [France] | Lack of yohimbine effect on ambulatory blood pressure recording : a double-blind cross-over trial in Parkinsonians with orthostatic hypotension |
| 001A04 | J. L. Montastruc [France] | Recent advances in the clinical pharmacology of Parkinson's disease |
| 001A91 | M. Berlan ; O. Rascol ; J. Belin ; J.-P. Moatti ; A. Rascol ; J.-L. Montastruc | α2-Adrenergic sensitivity in Parkinson's disease |
| This area was generated with Dilib version V0.6.29. |  |